Skip to main content
. 2006 Dec 5;96(1):143–150. doi: 10.1038/sj.bjc.6603501

Table 3. Impact of HPV 16/18 vaccine on abnormal cytology, diagnostic tests, and treated CIN lesions over the lifetime of a 12-year-old cohort in the United Kingdom.

  Abnormal cytology testa Colposcopy Biopsy Treated CIN lesions
0% vaccine coverage        
  311 983 153 245 99 974 38 437
         
100% vaccine coverage        
  237 734 111 504 67 367 22 123
         
Reduction owing to vaccine 74 249 41 741 32 607 16 314
% Reduction 23.8% 27.2% 32.6% 42.4%
a

Abnormal cytology test includes those with borderline dyskaryosis or greater.